CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Baptist Health System

Leslie Hurst, Associate Vice President of Specialty Pharmacy & PBM Strategy

Transforming Specialty Pharmacy: Strategic Leadership for Value-Based, Patient-Centered Care

Leslie Hurst

Leslie Hurst

Leslie Hurst serves as associate vice president of specialty pharmacy & PBM strategy at Baptist Health System (KY & IN). With extensive experience leading specialty pharmacy programs, she directs formulary strategy, benefit optimization and team operations, driving improved access, affordability and clinical outcomes across the health system. With a Doctor of Pharmacy from the University of Kentucky and board certification in ambulatory care, she excels in strategic planning and operational excellence. A former Walgreens specialty supervisor, she has advanced clinical practice, built high-performing teams, and enhanced medication adherence and outcomes. Hurst also champions health equity through speaking engagements (e.g., NASP) and community outreach, reinforcing her commitment to innovative, patient-centered care.


Shaping Pharmacy Strategy through Key Moments


I am committed to continuous learning and have consistently pursued opportunities that stretch my capabilities and expand my impact. A decade ago, I stepped into the evolving specialty pharmacy landscape, launching patient services in a rural market with complex access challenges. My leadership spans retail, specialty, health system, 340B, and PBM pharmacy. As I recognized the broader influence of specialty pharmacy on patient outcomes and total cost of care, I transitioned into health system pharmacy leadership—enabling end-to-end collaboration with providers to optimize medication access and adherence.


Aligning Pharmacy with Value-Based Care


Medication adherence is essential to achieving successful therapeutic outcomes. In specialty pharmacy, patients often face barriers such as high costs, complex administration requirements, and adverse effects, which can hinder adherence. Pharmacists and pharmacy technicians play a critical role in addressing these challenges by supporting patients to stay on therapy, optimizing medication use, and ultimately improving health outcomes while reducing hospitalizations and emergency department visits.


Turning Challenges into Opportunities


Cost transparency is a priority for our health plan and pharmacy benefits. As a large health system, we have insight into the total cost of care, access barriers, and the clinical and financial impact of pharmacy benefit design. In my current role, I lead our internal PBM Pharmacy & Therapeutics Committee, which guides the appropriate selection of medications and related products for our covered population. We are actively advancing generic utilization and biosimilar strategies to ensure employees and their dependents receive clinically appropriate, costeffective therapies.


Driving Innovation with Strategy


Integrating pharmacists and pharmacy care coordinators into medical groups and hospital-based clinics has accelerated pharmacy innovation across our organization. With the launch of our centralized pharmacy services center, we’ve established a scalable, efficient prescription fulfillment model while maintaining decentralized clinical medication management. This embedded, hands-on approach enhances patient support, improves provider satisfaction, and drives better medication-related outcomes. Integrated specialty pharmacy and medication fulfillment software with full EHR visibility provide a foundation for safe, efficient, and high-quality care.


Sage Advice


Proactively seek opportunities to independently build new skills and deepen expertise. Cultivate cross-organizational peer networks to enhance professional growth through collaboration. Attend strategic conferences to engage with industry stakeholders and share your team’s work to build visibility and foster partnerships for future innovation.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/transforming-specialty-pharmacy-strategic-leadership-for-valuebased-patientcentered-care-nwid-2865.html